Eli Lil­ly's CFO re­tir­ing af­ter 27 years at com­pa­ny; Alex­ion names a new slate of ex­ecs

→  Mi­na Sooch has re­signed as pres­i­dent, CEO, and di­rec­tor of Gem­phire, cit­ing “per­son­al rea­sons.” The com­pa­ny has strug­gled fi­nan­cial­ly and its drug can­di­date, gem­cabene, in-li­censed from Pfiz­er, has ex­pe­ri­enced road­blocks that are pre­vent­ing it from be­ing de­vel­oped. Pfiz­er has the right to get the drug back if Gem­phire does not suc­ceed in com­mer­cial­iz­ing it. Board mem­ber Dr. Steven Gul­lans will fill the role of pres­i­dent and CEO un­til the com­pa­ny finds a re­place­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.